(Q40428498)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15864318%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

title

Combination treatment significantly enhances the efficacy of antitumor therapy by preferentially targeting angiogenesis (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15864318%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15864318%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

author name string

Pawan Kumar

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15864318%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

Ryan Benedict

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15864318%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

Fernando Urzua

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15864318%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

David Mooney

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15864318%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

Peter Polverini

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15864318%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

language of work or name

1 reference

1 June 2005

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15864318%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

published in

Laboratory Investigation

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15864318%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

volume

85

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15864318%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15864318%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

page(s)

756-767

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15864318%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1038/labinvest.3700272

11 January 2020

exact match

0 references

cites work

Tumor angiogenesis: therapeutic implications

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700272

What Is the Evidence That Tumors Are Angiogenesis Dependent?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700272

Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700272

Angiopoietin-3 inhibits pulmonary metastasis by inhibiting tumor angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700272

Vascular endothelial growth factor (VEGF)-mediated angiogenesis is associated with enhanced endothelial cell survival and induction of Bcl-2 expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700272

The biology of vascular endothelial growth factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700272

Thrombospondin-1 induces endothelial cell apoptosis and inhibits angiogenesis by activating the caspase death pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700272

Vascular endothelial cell growth factor (VEGF), an emerging target for cancer chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700272

Continuous low-dose therapy with vinblastine and VEGF receptor-2 antibody induces sustained tumor regression without overt toxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700272

Possible mechanisms of acquired resistance to anti-angiogenic drugs: implications for the use of combination therapy approaches.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700272

Endothelial apoptosis as the primary lesion initiating intestinal radiation damage in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700272

p38 MAPK mediates gamma-irradiation-induced endothelial cell apoptosis, and vascular endothelial growth factor protects endothelial cells through the phosphoinositide 3-kinase-Akt-Bcl-2 pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700272

Akt phosphorylation of BAD couples survival signals to the cell-intrinsic death machinery

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700272

Regulation of cell death protease caspase-9 by phosphorylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700272

Cellular survival: a play in three Akts

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700272

Src and phosphatidylinositol 3-kinase mediate soluble E-selectin-induced angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700272

Acquired resistance to EGFR inhibitors: mechanisms and prevention strategies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700272

Hypoxia enhances vascular cell proliferation and angiogenesis in vitro via rapamycin (mTOR)-dependent signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700272

Radiation sensitization of human cancer cells in vivo by inhibiting the activity of PI3K using LY294002.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700272

Targeting tumor cells by enhancing radiation sensitivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700272

Tumour stem cells: the relevance of predictive assays for tumour control after radiotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700272

Transplacental carcinogenesis by stilbestrol

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700272

7 January 2021

Vascular endothelial growth factor (VEGF) and its receptors

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700272

7 January 2021

The combination of antiangiogenic agents to inhibit primary tumor growth and metastasis

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700272

7 January 2021

TNP-470 and recombinant human interferon-alpha2a inhibit angiogenesis synergistically

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700272

7 January 2021

Tumor response to radiotherapy regulated by endothelial cell apoptosis

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700272

7 January 2021

Engineering vascular networks in porous polymer matrices

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700272

7 January 2021

Potential indicators of radiosensitivity in squamous cell carcinoma of the head and neck

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700272

7 January 2021